Stem Cells in Racehorses

In the equine world, tendon and ligament injuries are bad news indeed.

Written byStephen Pincock
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

© John Kelly/The Image Bank

In the equine world, tendon and ligament injuries are bad news indeed. Among the many prized race and performance animals who suffer from bowed tendons or similar maladies each year, just 20% or so make a full recovery, and then only after a long and costly rehabilitation. The suffering and expense these injuries incur has led frustrated horse owners to try a host of different treatments for these injuries over time, some more evidence-based than others, and all without great success. Perhaps it was inevitable, then, that some in the veterinary world would turn to a therapeutic approach that scientists say holds such great promise in humans: stem cells.

In the past few years at least two companies, one in Britain and the other in the United States, have begun offering treatments that they say improve healing of the injuries by means of autologous adult ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies